We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 30 results
  1. Eradicating the tumor “seeds”: nanomedicines-based therapies against cancer stem cells

    Objectives

    Cancer stem cells (CSCs), a small subpopulation of cells with high tumorigenesis and strong intrinsic drug resistance, exhibit self-renewal...

    Lin Li, Rui Ni, ... Lin Chen in DARU Journal of Pharmaceutical Sciences
    Article 27 March 2023
  2. Amplifying gene expression with RNA-targeted therapeutics

    Many diseases are caused by insufficient expression of mutated genes and would benefit from increased expression of the corresponding protein....

    Olga Khorkova, Jack Stahl, ... Claes Wahlestedt in Nature Reviews Drug Discovery
    Article 30 May 2023
  3. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery

    Abstract

    Extracellular vesicles (EVs) are a promising drug delivery vehicle candidate because of their natural origin and intrinsic function of...

    Amir Hossein Mohammadi, Zeinab Ghazvinian, ... Kaveh Baghaei in BioDrugs
    Article 24 April 2023
  4. Plant-derived exosome-like nanoparticles for microRNA delivery in cancer treatment

    Plant-derived exosome-like nanoparticles (PELNs) are natural nanocarriers and effective delivery systems for plant microRNAs (miRNAs). These...

    Chun Yi, Linzhu Lu, ... Xuefei Tian in Drug Delivery and Translational Research
    Article 17 May 2024
  5. Blood Interactions with Nanoparticles During Systemic Delivery

    In the preceding chapter, different physiological, chemical, and bio-chemical barriers in systemic drug delivery have been introduced. In this...
    Chapter 2020
  6. The Mechanism of Nano-drug Delivery

    Most conventional drugs accumulate in non-target areas in the body of patients and are responsible for adverse side effects due to poor solubility...

    Siying Li, Hongda Wang, Yu** Shan in Current Pharmacology Reports
    Article 05 December 2019
  7. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice

    RNA is rapidly emerging as a versatile building block for nanoparticle assembly due to its simplicity in base pairing, while exhibiting diversity in...
    Farzin Haque, Congcong Xu, ... Peixuan Guo in RNA Nanostructures
    Protocol 2017
  8. Emerging Therapeutic Approaches to Overcome Breast Cancer Endocrine Resistance

    Antiestrogen therapies have been a staple treatment option for estrogen receptor (ER)-positive breast cancer patients for many decades, but...
    Marissa Leonard, Juan Tan, ... **aoting Zhang in Estrogen Receptor and Breast Cancer
    Chapter 2019
  9. Estrogen receptor coactivator Mediator Subunit 1 (MED1) as a tissue-specific therapeutic target in breast cancer

    Breast cancer, one of the most frequent cancer types, is a leading cause of death in women worldwide. Estrogen receptor (ER) a is a nuclear hormone...

    Marissa Leonard, **aoting Zhang in Journal of Zhejiang University-SCIENCE B
    Article 16 May 2019
  10. Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?

    Cyclin-dependent kinases (CDK) control the cell cycle and play a crucial role in oncogenesis. Pharmacologic inhibition of CDK has contributed to the...

    Christin Riess, Nina Irmscher, ... Claudia Maletzki in Cancer and Metastasis Reviews
    Article Open access 08 November 2020
  11. Fabrication of Electrochemical-Based Bioelectronic Device and Biosensor Composed of Biomaterial-Nanomaterial Hybrid

    The field of bioelectronics has paved the way for the development of biochips, biomedical devices, biosensors and biocomputation devices. Various...
    Mohsen Mohammadniaei, Chulhwan Park, ... Taek Lee in Biomimetic Medical Materials
    Chapter 2018
  12. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

    Background

    Triple-negative breast cancer (TNBC) is a poor prognostic breast cancer with the highest mutations and limited therapeutic choices....

    Yueh-Shan Weng, Hong-Yu Tseng, ... Hsin-Ling Hsu in Molecular Cancer
    Article Open access 18 March 2019
  13. Assembling RNA Nanoparticles

    RNA nanoparticles are designed and self-assembled according to noncanonical interactions of naturally conserved RNA motifs and/or canonical...
    Shou-Jun **ao in 3D DNA Nanostructure
    Protocol 2017
  14. Evaluation of Thermal Stability of RNA Nanoparticles by Temperature Gradient Gel Electrophoresis (TGGE) in Native Condition

    Temperature gradient gel electrophoresis (TGGE) is a powerful tool used to analyze the thermal stabilities of nucleic acids. While TGGE is a...
    Kheiria Benkato, Benjamin O’Brien, ... Emil F. Khisamutdinov in RNA Nanostructures
    Protocol 2017
  15. Multifunctional Nanoprobes for Theranostics of Gastric Cancer

    Gastric cancer therapeutic strategies still focus on early diagnosis and operation therapy, enhanced immunotherapy, and killing gastric cancer stem...
    Chapter 2017
  16. Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond

    Malignant brain tumors are rapidly progressive and often fatal owing to resistance to therapies and based on their complex biology, heterogeneity,...

    Anna M. Krichevsky, Erik J. Uhlmann in Neurotherapeutics
    Article Open access 14 January 2019
  17. Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases

    Efficient treatment of ocular diseases can be achieved thanks to the proper use of ophthalmic formulations based on emerging pharmaceutical...

    I. Bravo-Osuna, V. Andrés-Guerrero, ... R. Herrero-Vanrell in Drug Delivery and Translational Research
    Article 20 October 2016
  18. Ocular Delivery of pRNA Nanoparticles: Distribution and Clearance After Subconjunctival Injection

    Purpose

    RNA nanoparticles derived from the three-way junction (3WJ) of the pRNA of bacteriophage phi29 DNA packaging motor were previously found to be...

    Liang Feng, S. Kevin Li, ... Peixuan Guo in Pharmaceutical Research
    Article 03 December 2013
  19. Aptamers as targeted therapeutics: current potential and challenges

    Nucleic acid aptamers, often termed 'chemical antibodies', are functionally comparable to traditional antibodies, but offer several advantages,...

    Jiehua Zhou, John Rossi in Nature Reviews Drug Discovery
    Article 03 November 2016
  20. RNA interference approaches for treatment of HIV-1 infection

    HIV/AIDS is a chronic and debilitating disease that cannot be cured with current antiretroviral drugs. While combinatorial antiretroviral therapy...

    Maggie L Bobbin, John C Burnett, John J Rossi in Genome Medicine
    Article Open access 28 May 2015
Did you find what you were looking for? Share feedback.